Structure-activity relationship in the effects of delta-sleep-inducing peptide (DSIP) on rat sleep. 1986

F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke

DSIP and its analogues, [D-Trp1]-DSIP, [D-Tyr1]-DSIP, and [D-Trp1]-DSIP1-6, were injected ICV (7 nmol/kg) into rats at dark onset, and the sleep-wake activity was recorded during the 12-hr dark period and the subsequent 12-hr light period. The effects were evaluated with respect to baseline records obtained after artificial CSF injections. DSIP did not increase sleep, whereas both [D-Trp1]-DSIP and [D-Tyr1]-DSIP promoted sleep in the first part of the night. [D-Trp1]-DSIP1-6 had a prompt arousing effect. It is suggested that the sleep-promoting analogues act by facilitating slight endogenous sleep tendencies at some time after dark onset, while DSIP is degraded quickly and is therefore not effective. The increase of W after [D-Trp1]-DSIP1-6 may indicate that DSIP contains a fragment with an arousing effect. The results corroborate the notion that the active DSIP molecule has a pseudo-cyclic structure.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003701 Delta Sleep-Inducing Peptide A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal. DSIP,Delta Sleep Inducing Peptide,Delta-Sleep Peptide,Delta-Sleep-Inducing Peptide,Delta-Sleep-Inducing-Peptide,Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu,Delta Sleep Peptide,Peptide, Delta Sleep-Inducing,Peptide, Delta-Sleep,Peptide, Delta-Sleep-Inducing,Sleep-Inducing Peptide, Delta,Trp Ala Gly Gly Asp Ala Ser Gly Glu
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D012894 Sleep Stages Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; they formerly included Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. In 2007, sleep stages were redefined by The American Academy of Sleep Medicine (AASM) as: N1-N2 (sleep onset - light sleep), N3 (SLOW-WAVE SLEEP), and REM SLEEP. N1-Sleep,N2-Sleep,NREM Stage 1,NREM Stage 2,N1 Sleep,N2 Sleep,Sleep Stage,Stage, Sleep,Stages, Sleep
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1984, European neurology,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1984, Neuroscience and biobehavioral reviews,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1986, Peptides,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
February 1986, European journal of pharmacology,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
February 1983, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
August 1981, International journal of clinical pharmacology, therapy, and toxicology,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1980, Waking and sleeping,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1982, Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
June 1987, Brain research,
F Obál, and V M Kovalzon, and V N Kalikhevich, and A Török, and P Alföldi, and G Sáry, and M Hajós, and B Penke
January 1981, Experientia,
Copied contents to your clipboard!